Repligen Stock Quote
$154.67 -$1.21 -0.8%
Price as of August 6, 2020, 4:30 p.m. EDT View Interactive RGEN Charts

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

Interactive Chart

News & Analysis: Repligen

The Fool has written over 100 articles on Repligen.


Market Moves


2 Top U.S. Stocks to Watch in April

These two stocks can be used to gauge how the pharmaceutical industry and energy sector are faring during the coronavirus pandemic -- and what might be ahead.

5 Numbers Repligen Investors Need to Know

Drilling down in the numbers shows how the bioprocess leader became one of the best growth stocks on the market -- and how it remains well-positioned for long-term growth.